Lipid nanoparticle platform delivers chemo drug and RNA to boost immune response against lung cancer
By
University of ArizonaJun 25 2026Reviewed
Summary
Researchers at the University of Arizona have developed a nanotechnology-based platform using lipid nanoparticles to deliver a chemotherapy drug (paclitaxel) and an RNA molecule (siRNA) together, boosting the immune system's ability to recognize and attack lung cancer tumors. The approach slowed tumor growth and enhanced immunotherapy effects, as published in Nature Communications.
Source
bskyLipid nanoparticle platform delivers chemo drug and RNA to boost immune response against lung cancernews-medical.netKey quotes
· 3 pulledBy packaging a chemotherapy drug and an RNA molecule in a tiny lipid carrier, the team boosted an immune response that slowed tumor growth and enhanced the effects of immunotherapy.
The findings, published in Nature Communications, describe a nanotechnology-based platform that combines the chemotherapy drug paclitaxel with a gene-silencing molecule known as siRNA.
Researchers at the University of Arizona R. Ken Coit College of Pharmacy have developed a new strategy that helps the immune system recognize and attack lung cancer tumors more effectively.
You might also wanna read
Anti-inflammatory drugs show promise for lung cancer prevention, new research finds
New research indicates that existing anti-inflammatory drugs show promise for preventing lung cancer, moving beyond traditional lifestyle-ba
economist.com·18d ago
Scientists Develop Universal Cancer Vaccine Using mRNA Technology
Scientists have developed a 'universal cancer vaccine' using mRNA technology that can train the immune system to target any type of cancer,
newatlas.com·11mo ago
Manganese perovskite nanocubes convert cold tumors to hot in hepatocellular carcinoma via PANoptosis/STING activation
This article presents a novel nanosystem for treating hepatocellular carcinoma (HCC) by converting immunologically "cold" tumors into "hot"
scim.ag·15d ago
Oregon State University Researchers Develop Iron Nanomaterial That Selectively Destroys Cancer Cells
Researchers at Oregon State University have developed a novel iron-based nanomaterial that targets and destroys cancer cells from within. Th
Engineered immunotherapy drug eliminates aggressive metastatic cancers in clinical trial
Researchers at Rockefeller University have developed an engineered CD40 agonist antibody that successfully eliminated aggressive metastatic
rockefeller.edu·10mo ago
BEACONs: A novel nanoparticle adjuvant approach for mucosal vaccination against genital herpes
This article presents research on a novel adjuvant called BEACONs (Bioactive Enhanced Adjuvant Chemokine Oligonucleotide Nanoparticles) deve
scim.ag·10d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.